Projektdetails
Goal of the project
The project aims to evaluate and suggest combination of antimicrobials such as antibiotics, lytic phages, phage-borne enzymes, and anti-persister agents (including toxin-antitoxin systems, quorum-sensing network inhibitors, and ppGpp signaling inhibitors) for administration in treatment of infections caused by MDR bacteria. One of the tasks of the project is the creation of a biobank of K. pneumoniae, P. aeruginosa, and A. baumannii strains, and the development of AntiPERS Phage. PHAGES-AntiPERS fit the scope of the call.
Funding acknowledgement
The RMA participates in this project as non-funded partner.
| Kurztitel | Phage Therapy Antipersister strategy |
|---|---|
| Akronym | PHAGES-AntiPERS |
| Status | Laufend |
| Tatsächlicher Beginn/ -es Ende | 1/04/25 → 31/03/28 |
Projektbeteiligte
- Royal Military Academy
- Biomedical Research Institute of A Coruña (Leitung)
- Instituto de Salud Carlos III
- University of Wroclaw
- Hadassah University Medical Center
- Norwich Research Park
Fingerprint
Erkunden Sie die Forschungsthemen, die von diesem Projekt angesprochen werden. Diese Bezeichnungen werden den ihnen zugrunde liegenden Bewilligungen/Fördermitteln entsprechend generiert. Zusammen bilden sie einen einzigartigen Fingerprint.